Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew J Adams

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
NPJ Precision Oncology|September 12, 2018
Case study: patient-derived clear cell adenocarcinoma xenograft model longitudinally predicts treatment responseRoberto Vargas, Priyanka Gopal, Gwendolyn B Kuzmishin, et al.
ACS Chemical Biology|July 25, 2014
NAMPT is the cellular target of STF-31-like small-molecule probesDrew J Adams, Daisuke Ito, Matthew G Rees, et al.
RSC Chemical Biology|February 7, 2022
Inhibition of SC4MOL and HSD17B7 shifts cellular sterol composition and promotes oligodendrocyte formationMatthew J Pleshinger, Ryan M Friedrich, Zita Hubler, et al.
Stem Cell Reports|January 11, 2019
A miRNA-Mediated Approach to Dissect the Complexity of Tumor-Initiating Cell Function and Identify miRNA-Targeting DrugsAnil Belur Nagaraj, Peronne Joseph, Erin Ponting, et al.
The Journal of Clinical Investigation|September 10, 2019
Ex vivo screen identifies CDK12 as a metastatic vulnerability in osteosarcomaIan Bayles, Malgorzata Krajewska, W Dean Pontius, et al.
Nature Communications|November 15, 2019
Clonal selection confers distinct evolutionary trajectories in BRAF-driven cancersPriyanka Gopal, Elif Irem Sarihan, Eui Kyu Chie, et al.
Cancer Research|August 28, 2013
Integrative radiogenomic profiling of squamous cell lung cancerMohamed E Abazeed, Drew J Adams, Kristen E Hurov, et al.
Nature Chemical Biology|March 26, 2024
Targeting the chromatin binding of exportin-1 disrupts NFAT and T cell activationYi Fan Chen, Maryam Ghazala, Ryan M Friedrich, et al.
Stem Cell Reports|August 28, 2018
Chemical Screening Identifies Enhancers of Mutant Oligodendrocyte Survival and Unmasks a Distinct Pathological Phase in Pelizaeus-Merzbacher DiseaseMatthew S Elitt, H Elizabeth Shick, Mayur Madhavan, et al.
Nature Communications|April 26, 2016
A genetic basis for the variation in the vulnerability of cancer to DNA damageBrian D Yard, Drew J Adams, Eui Kyu Chie, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
NPJ Precision Oncology|September 12, 2018
Case study: patient-derived clear cell adenocarcinoma xenograft model longitudinally predicts treatment responseRoberto Vargas, Priyanka Gopal, Gwendolyn B Kuzmishin, et al.
ACS Chemical Biology|July 25, 2014
NAMPT is the cellular target of STF-31-like small-molecule probesDrew J Adams, Daisuke Ito, Matthew G Rees, et al.
RSC Chemical Biology|February 7, 2022
Inhibition of SC4MOL and HSD17B7 shifts cellular sterol composition and promotes oligodendrocyte formationMatthew J Pleshinger, Ryan M Friedrich, Zita Hubler, et al.
Stem Cell Reports|January 11, 2019
A miRNA-Mediated Approach to Dissect the Complexity of Tumor-Initiating Cell Function and Identify miRNA-Targeting DrugsAnil Belur Nagaraj, Peronne Joseph, Erin Ponting, et al.
The Journal of Clinical Investigation|September 10, 2019
Ex vivo screen identifies CDK12 as a metastatic vulnerability in osteosarcomaIan Bayles, Malgorzata Krajewska, W Dean Pontius, et al.
Nature Communications|November 15, 2019
Clonal selection confers distinct evolutionary trajectories in BRAF-driven cancersPriyanka Gopal, Elif Irem Sarihan, Eui Kyu Chie, et al.
Cancer Research|August 28, 2013
Integrative radiogenomic profiling of squamous cell lung cancerMohamed E Abazeed, Drew J Adams, Kristen E Hurov, et al.
Nature Chemical Biology|March 26, 2024
Targeting the chromatin binding of exportin-1 disrupts NFAT and T cell activationYi Fan Chen, Maryam Ghazala, Ryan M Friedrich, et al.
Stem Cell Reports|August 28, 2018
Chemical Screening Identifies Enhancers of Mutant Oligodendrocyte Survival and Unmasks a Distinct Pathological Phase in Pelizaeus-Merzbacher DiseaseMatthew S Elitt, H Elizabeth Shick, Mayur Madhavan, et al.
Nature Communications|April 26, 2016
A genetic basis for the variation in the vulnerability of cancer to DNA damageBrian D Yard, Drew J Adams, Eui Kyu Chie, et al.
Pageof 5